CT Evaluation of Cardiovascular Risk Markers in Obese Patients
RisqOScan
2 other identifiers
observational
123
1 country
1
Brief Summary
Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early atherosclerosis. Coronary artery calcium measured by CT is known as a robust predictor to predict risk for cardiac events in symptomatic and asymptomatic individuals. Furthermore, recent studies show that other CT risk factor exists, independent of calcium scoring, such as epicardial fat, intrathoracic fat and visceral fat. The aim of this prospective study is to evaluate these new cardiovascular risk markers in obese patients, using standard dose CT and low dose CT with adaptative statistical iterative reconstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 30, 2017
CompletedFirst Posted
Study publicly available on registry
April 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedApril 13, 2017
April 1, 2017
3.1 years
March 30, 2017
April 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Epicardial fat evaluation in obese population
at day 1
Secondary Outcomes (1)
Calcium scoring evaluation
at day 1
Study Arms (1)
obese patients
obese patients of our clinical nutrition service, hospitalized for nutrional assessement, are included.
Interventions
All unenhanced coroCT examinations are performed on the same 64-Row CT scanner (discovery CT 750 HD scanner, GE Helthcare), using prospective ECG-triggerring.
Eligibility Criteria
obese population
You may qualify if:
- obesity \>30 indicated non enhanced coroCT for calcium scoring.
You may not qualify if:
- \<18 ans
- low Framingham scoring
- pregnancy
- not providing informed consent
- history of cardiovascular disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucie CASSAGNES
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2017
First Posted
April 13, 2017
Study Start
November 1, 2014
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
April 13, 2017
Record last verified: 2017-04